Relapse prevention after index electroconvulsive therapy in treatment-resistant depression

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

BACKGROUND: One-third of patients who suffer from depression are resistant to conventional treatments. An acute course of electroconvulsive therapy (ECT) can lead to remission of depressive symptoms in a substantial portion of the treatment-resistant patients. However, prevention of relapse with depressive symptoms after the index course of ECT can be challenging. We review pertinent studies on the topic and analyze the best strategies to avoid relapse and recurrence of depressive symptoms. METHODS: We performed a systematic literature review of PubMed through April 2014 for clinical trials published in English to determine if continuation ECT (C-ECT), continuation medication, continuation psychotherapy, or combinations of these are the best strategy to avoid relapse and recurrence of depressive symptoms after an acute course of ECT. Clinical trials comparing ≥2 of the above strategies were included in the review. RESULTS: Although there are few rigorous randomized clinical trials in this area, most studies suggest that combined C-ECT and continuation pharmacotherapy are the most effective strategy in relapse prevention. CONCLUSIONS: C-ECT and continuation pharmacotherapy may be more effective than either alone for preventing relapse. However, more definitive randomized clinical trials are needed.

Original languageEnglish (US)
Pages (from-to)288-296
Number of pages9
JournalAnnals of Clinical Psychiatry
Volume26
Issue number4
StatePublished - Jan 1 2014

Fingerprint

Treatment-Resistant Depressive Disorder
Electroconvulsive Therapy
Secondary Prevention
Depression
Recurrence
Randomized Controlled Trials
Clinical Trials
Drug Therapy
PubMed
Psychotherapy
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Relapse prevention after index electroconvulsive therapy in treatment-resistant depression. / Youssef, Nagy Adel; McCall, William Vaughn.

In: Annals of Clinical Psychiatry, Vol. 26, No. 4, 01.01.2014, p. 288-296.

Research output: Contribution to journalReview article

@article{d6d0197ee8e84daba68835b25bab7cad,
title = "Relapse prevention after index electroconvulsive therapy in treatment-resistant depression",
abstract = "BACKGROUND: One-third of patients who suffer from depression are resistant to conventional treatments. An acute course of electroconvulsive therapy (ECT) can lead to remission of depressive symptoms in a substantial portion of the treatment-resistant patients. However, prevention of relapse with depressive symptoms after the index course of ECT can be challenging. We review pertinent studies on the topic and analyze the best strategies to avoid relapse and recurrence of depressive symptoms. METHODS: We performed a systematic literature review of PubMed through April 2014 for clinical trials published in English to determine if continuation ECT (C-ECT), continuation medication, continuation psychotherapy, or combinations of these are the best strategy to avoid relapse and recurrence of depressive symptoms after an acute course of ECT. Clinical trials comparing ≥2 of the above strategies were included in the review. RESULTS: Although there are few rigorous randomized clinical trials in this area, most studies suggest that combined C-ECT and continuation pharmacotherapy are the most effective strategy in relapse prevention. CONCLUSIONS: C-ECT and continuation pharmacotherapy may be more effective than either alone for preventing relapse. However, more definitive randomized clinical trials are needed.",
author = "Youssef, {Nagy Adel} and McCall, {William Vaughn}",
year = "2014",
month = "1",
day = "1",
language = "English (US)",
volume = "26",
pages = "288--296",
journal = "Annals of Clinical Psychiatry",
issn = "1040-1237",
publisher = "Dowden Health Media,Inc",
number = "4",

}

TY - JOUR

T1 - Relapse prevention after index electroconvulsive therapy in treatment-resistant depression

AU - Youssef, Nagy Adel

AU - McCall, William Vaughn

PY - 2014/1/1

Y1 - 2014/1/1

N2 - BACKGROUND: One-third of patients who suffer from depression are resistant to conventional treatments. An acute course of electroconvulsive therapy (ECT) can lead to remission of depressive symptoms in a substantial portion of the treatment-resistant patients. However, prevention of relapse with depressive symptoms after the index course of ECT can be challenging. We review pertinent studies on the topic and analyze the best strategies to avoid relapse and recurrence of depressive symptoms. METHODS: We performed a systematic literature review of PubMed through April 2014 for clinical trials published in English to determine if continuation ECT (C-ECT), continuation medication, continuation psychotherapy, or combinations of these are the best strategy to avoid relapse and recurrence of depressive symptoms after an acute course of ECT. Clinical trials comparing ≥2 of the above strategies were included in the review. RESULTS: Although there are few rigorous randomized clinical trials in this area, most studies suggest that combined C-ECT and continuation pharmacotherapy are the most effective strategy in relapse prevention. CONCLUSIONS: C-ECT and continuation pharmacotherapy may be more effective than either alone for preventing relapse. However, more definitive randomized clinical trials are needed.

AB - BACKGROUND: One-third of patients who suffer from depression are resistant to conventional treatments. An acute course of electroconvulsive therapy (ECT) can lead to remission of depressive symptoms in a substantial portion of the treatment-resistant patients. However, prevention of relapse with depressive symptoms after the index course of ECT can be challenging. We review pertinent studies on the topic and analyze the best strategies to avoid relapse and recurrence of depressive symptoms. METHODS: We performed a systematic literature review of PubMed through April 2014 for clinical trials published in English to determine if continuation ECT (C-ECT), continuation medication, continuation psychotherapy, or combinations of these are the best strategy to avoid relapse and recurrence of depressive symptoms after an acute course of ECT. Clinical trials comparing ≥2 of the above strategies were included in the review. RESULTS: Although there are few rigorous randomized clinical trials in this area, most studies suggest that combined C-ECT and continuation pharmacotherapy are the most effective strategy in relapse prevention. CONCLUSIONS: C-ECT and continuation pharmacotherapy may be more effective than either alone for preventing relapse. However, more definitive randomized clinical trials are needed.

UR - http://www.scopus.com/inward/record.url?scp=84929071609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929071609&partnerID=8YFLogxK

M3 - Review article

C2 - 25401716

AN - SCOPUS:84929071609

VL - 26

SP - 288

EP - 296

JO - Annals of Clinical Psychiatry

JF - Annals of Clinical Psychiatry

SN - 1040-1237

IS - 4

ER -